Latka logo

Medchat vs Stotles: Revenue, Funding & Team Size Compared

Medchat generates $3.6M in revenue; Stotles generates $3.6M. Stotles and Medchat are close to the same size by revenue. The table below compares Medchat and Stotles on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

Medchat vs Stotles compared on revenue, funding, valuation, customers and team size
CompanyMedchat logoMedchatThis companyStotles logoStotles
Revenue$3.6M$3.6M
ValuationNot disclosed$21.7M
Funding raisedNot disclosed$1.8M
Team size2460
Founded20162019
HQCharlotte, United StatesLondon, United Kingdom

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

Medchat logo

Medchat at a glance

Medchat generates $3.6M in revenue with 24 employees, headquartered in Charlotte, United States.

Revenue
$3.6M
Team size
24
Founded
2016

Communication platform used in health care organizations offering HIPAA-compliant live chat, chatbots and two-way texts

Stotles logo

Stotles at a glance

Stotles generates $3.6M in revenue with 60 employees, headquartered in London, United Kingdom.

Revenue
$3.6M
Valuation
$21.7M
Funding
$1.8M
Team size
60
Founded
2019

The SaaS platform unlocking the potential of business and government working better, together.

Other Medchat alternatives

Medchat competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

Medchat vs Stotles: frequently asked questions

Is Medchat or Stotles bigger?

Stotles is the bigger company by revenue, at $3.6M against $3.6M for Medchat.

How much revenue does Medchat make?

Medchat generates $3.6M in annual revenue with a team of 24.

How much revenue does Stotles make?

Stotles generates $3.6M in annual revenue with a team of 60.

How much funding has Stotles raised?

Stotles has raised $1.8M in total funding since it was founded in 2019.